Wu X - Search Results

1

Gemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III Study.

Hong S, Zhang Y, Yu G, Peng P, Peng J, Jia J, Wu X, Huang Y, Yang Y, Lin Q, Xi X, Xu M, Chen D, Lu X, Wang R, Cao X, Chen X, Lin Z, Xiong J, Lin Q, Xie C, Li Z, Pan J, Li J, Wu S, Lian Y, Yang Q, Zhao C, Fang W, Zhang L. Hong S, et al. Among authors: wu x, wu s. J Clin Oncol. 2021 Oct 10;39(29):3273-3282. doi: 10.1200/JCO.21.00396. Epub 2021 Aug 11. J Clin Oncol. 2021. PMID: 34379443 Free PMC article. Clinical Trial.

2

[Analysis of the relationship between the response after the First-line chemotherapy and the survival in the advanced non-small cell lung cancer.].

Lin L, Xiang X, Huang H, Zhao H, Zhang Y, Wu J, Zhao Y, Wu X, Zhang L. Lin L, et al. Among authors: wu x, wu j. Zhongguo Fei Ai Za Zhi. 2008 Jun 20;11(3):333-8. doi: 10.3779/j.issn.1009-3419.2008.03.015. Zhongguo Fei Ai Za Zhi. 2008. PMID: 20731929 Free article. Chinese.

3

[Predictive factors of gefitinib response and survival in Chinese patients with local advanced or metastatic non-small cell lung cancer].

Lin L, Zhang L, Zhao H, Lin L, Wu X, Zhang Y, Guan Z. Lin L, et al. Among authors: wu x. Zhongguo Fei Ai Za Zhi. 2007 Oct 20;10(5):411-7. doi: 10.3779/j.issn.1009-3419.2007.05.13. Zhongguo Fei Ai Za Zhi. 2007. PMID: 21126411 Free article. Chinese.

4

The impact of both platinum-based chemotherapy and EGFR-TKIs on overall survival of patients with advanced non-small cell lung cancer.

Zhang JW, Zhao YY, Guo Y, Xue C, Hu ZH, Huang Y, Zhao HY, Zhang J, Wu X, Fang WF, Ma YX, Zhang L. Zhang JW, et al. Among authors: wu x. Chin J Cancer. 2014 Feb;33(2):105-14. doi: 10.5732/cjc.012.10274. Epub 2013 Jul 2. Chin J Cancer. 2014. PMID: 23816558 Free PMC article.

5

Serum proteomic study on EGFR-TKIs target treatment for patients with NSCLC.

Wu X, Liang W, Hou X, Lin Z, Zhao H, Huang Y, Fang W, Zhao Y, Wu J, Yang Y, Xue C, Hu Z, Zhang J, Zhang J, Ma Y, Zhou T, Qin T, Zhang L. Wu X, et al. Among authors: wu j. Onco Targets Ther. 2013 Oct 21;6:1481-91. doi: 10.2147/OTT.S51887. eCollection 2013. Onco Targets Ther. 2013. PMID: 24204163 Free PMC article.

6

Efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors for Chinese patients with squamous cell carcinoma of lung harboring EGFR mutation.

Fang W, Zhang J, Liang W, Huang Y, Yan Y, Wu X, Hu Z, Ma Y, Zhao H, Zhao Y, Yang Y, Xue C, Zhang J, Zhang L. Fang W, et al. Among authors: wu x. J Thorac Dis. 2013 Oct;5(5):585-92. doi: 10.3978/j.issn.2072-1439.2013.09.15. J Thorac Dis. 2013. PMID: 24255770 Free PMC article.

7

Network meta-analysis of erlotinib, gefitinib, afatinib and icotinib in patients with advanced non-small-cell lung cancer harboring EGFR mutations.

Liang W, Wu X, Fang W, Zhao Y, Yang Y, Hu Z, Xue C, Zhang J, Zhang J, Ma Y, Zhou T, Yan Y, Hou X, Qin T, Dinglin X, Tian Y, Huang P, Huang Y, Zhao H, Zhang L. Liang W, et al. Among authors: wu x. PLoS One. 2014 Feb 12;9(2):e85245. doi: 10.1371/journal.pone.0085245. eCollection 2014. PLoS One. 2014. PMID: 24533047 Free PMC article.

8

Network meta-analysis on prophylactic regimens against recurrent hepatitis B virus infection after liver transplantation.

Zhang Y, Kang S, Fang W, Wu X, Liang W. Zhang Y, et al. Among authors: wu x. Hepatobiliary Surg Nutr. 2013 Dec;2(6):297-303. doi: 10.3978/j.issn.2304-3881.2013.11.02. Hepatobiliary Surg Nutr. 2013. PMID: 24570966 Free PMC article.

9

An investigation of symptom burden and quality of life in Chinese chemo-naïve advanced lung cancer patients by using the Instrument-Cloud QOL System.

Ma Y, Yang Y, Huang Y, Zhao H, Hou X, Tian Y, Zhao Y, Xue C, Fang W, Wu X, Hu Z, Liang W, Zhou T, Qin T, Zhang L. Ma Y, et al. Among authors: wu x. Lung Cancer. 2014 Jun;84(3):301-6. doi: 10.1016/j.lungcan.2014.01.027. Epub 2014 Feb 7. Lung Cancer. 2014. PMID: 24576536

10

Safety and efficacy of S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy: multi-institutional retrospective analysis.

Peng PJ, Cheng H, Ou XQ, Zeng LJ, Wu X, Liu YM, Lin Z, Tang YN, Wang SY, Zhang HY, Chen ZB. Peng PJ, et al. Among authors: wu x. Drug Des Devel Ther. 2014 Aug 14;8:1083-7. doi: 10.2147/DDDT.S67592. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 25152614 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54,551 results

Search Page